Hsing-Pang Hsieh

Director/ Distinguished Investigator
National Health Research Institutes/ Institute of Biotechnology and Pharmaceutical Research

​

Hsing-Pang Hsieh, Ph.D.
Distinguished Investigator/Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes
Jointly Appointed Professor, Department of Chemistry, National Tsing Hua University
Jointly Appointed Research Fellow, Biomedical Translation Research Center (BioTReC), National Biotechnology Research Park (NBRP), Academia Sinica
hphsieh@nhri.edu.tw
 
EDUCATION
Ph.D., Organic Chemistry, State University of New York
M.S., Organic Chemistry, National Tsing Hua University
B.S., Chemistry, National Tsing Hua University
 
PROFESSIONAL EXPERIENCES
1. Group Leader, Research Division, Central Epidemic Command Center for COVID-19. (2020/7 – 2023/4) 
2. Associate Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes. (2015/4-2019/12)
3. Director-General, Department of Research Planning and Development, National Health Research Institutes. (2012-2014)
4. Director, Technology Transfer and Incubation Center, National Health Research Institutes. (2009-2012)
5. Chief, Library, National Health Research Institutes. (2007-2009)

​Dr. Hsing-Pang Hsieh’s lab specializes in drug discovery and the development of novel anticancer drugs, following the approach of “From Bench to Bedside.” Dr. Hsieh has published 154 scientific journals, including 31 papers in the Journal of Medicinal Chemistry, a leading publication in the field of medicinal chemistry. He holds over 70 composition patents granted worldwide. Notably, he invented three clinical candidates: (A) DBPR112, which received IND approval from the US FDA and TFDA and has been undergoing Phase Ib/II clinical trials in Taiwan since 2022; (B) DBPR114, approved for IND by the US FDA and TFDA in 2017 and enter Phase I clinical trial in 2025 in Taiwan; and (C) DBPR104 was completed Phase II clinical trials in Taiwan.
His achievements have earned him numerous accolades, including being named The 68th Ministry of Education Academic Award (2024), a National Academy of Inventors (NAI) Fellow in 2023, and receiving the MOST Outstanding Research Award twice (2010, 2017), the Wang Ming-Ning Award (2016), the TECO Award (2013), and the TienTe Lee Outstanding Award (2008).

 

Speech title & Synopsis

Panel Discussion

as Moderator